TickerFacts.

Company research / AWHL

Aspira Women's Health Inc. (AWHL)

Build a valuation ↗↓ Download CSV

CIK 0000926617 · OTC · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Aspira Women's Health Inc. reported revenue of $343.0K. Revenue grew 8475.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

1724.5%
Gross margin
-2307.0%
Operating margin
-3725.9%
Net margin
8475.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312022-09-302022-06-302022-03-312021-12-312020-12-312019-12-31
Revenue$343.0K$4.0K$87.00M$8.18M———$6.81M$4.65M$4.54M
Cost of Revenue$3.30M$3.70M$3.89M$3.86M———$3.75M$3.42M$3.34M
Gross Profit$5.92M$5.48M$5.26M$4.32M———$3.06M$1.24M$1.20M
Operating Income-$7.91M-$16.28M-$18.85M-$31.14M———-$32.59M-$17.98M-$15.28M
Net Income-$12.78M-$13.09M-$16.69M-$29.89M———-$31.66M-$17.91M-$15.24M
EPS (Diluted)$-0.37$-0.93$-1.81$-3.85———$-4.27$-0.18$-0.18
Total Assets$5.46M$5.49M$6.26M$17.37M$23.94M——$41.08M$19.61M$13.83M
Total Liabilities$12.39M$8.05M$8.63M$10.39M$12.76M——$10.91M$9.89M$5.09M
Shareholders' Equity-$6.93M-$2.56M-$2.37M$6.98M$11.18M$14.12M$21.74M$30.17M$9.72M$8.74M
Cash & Equivalents$1.75M$1.77M$2.60M$13.31M$20.55M——$37.18M$16.63M—
Operating Cash Flow-$7.03M-$12.11M-$15.89M-$31.07M———-$27.39M-$14.73M-$12.96M
Capital Expenditures$16.0K$37.0K$24.0K$232.0K———$184.0K$490.0K$133.0K
Shares Outstanding43.48M17.41M10.65M8.31M8.30M——7.48M104.62M97.29M
Weighted Average Diluted Shares34.10M14.13M9.23M7.77M———7.41M100.72M86.60M
EPS (Basic)$-0.37$-0.93$-1.81$-3.85———$-4.27$-0.18$-0.18